| MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency A Gaspar-Maia, ZA Qadeer, D Hasson, K Ratnakumar, N Adrian Leu, ... Nature communications 4 (1), 1565, 2013 | 217 | 2013 |
| ATRX and DAXX: Mechanisms and Mutations MA Dyer, ZA Qadeer, D Valle-Garcia, E Bernstein Cold Spring Harbor perspectives in medicine 7 (3), a026567, 2017 | 204 | 2017 |
| Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes L Emdad, SL D'Souza, HP Kothari, ZA Qadeer, IM Germano Stem cells and development 21 (3), 404-410, 2012 | 171 | 2012 |
| Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ... Cell reports 16 (2), 472-486, 2016 | 106 | 2016 |
| ATRX binds to atypical chromatin domains at the 3′ exons of zinc finger genes to preserve H3K9me3 enrichment D Valle-Garcia, ZA Qadeer, DS McHugh, FG Ghiraldini, AH Chowdhury, ... Epigenetics 11 (6), 398-414, 2016 | 78 | 2016 |
| ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures ZA Qadeer, D Valle-Garcia, D Hasson, Z Sun, A Cook, C Nguyen, ... Cancer Cell 36 (5), 512-527. e9, 2019 | 75 | 2019 |
| Stemness of the CT-2A immunocompetent mouse brain tumor model: characterization in vitro E Binello, ZA Qadeer, HP Kothari, L Emdad, IM Germano Journal of cancer 3, 166, 2012 | 73 | 2012 |
| Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas IM Germano, L Emdad, ZA Qadeer, E Binello, M Uzzaman Cancer gene therapy 17 (9), 664-674, 2010 | 45 | 2010 |
| Decreased expression of the chromatin remodeler ATRX associates with melanoma progression ZA Qadeer, S Harcharik, D Valle-Garcia, C Chen, MB Birge, ... The Journal of investigative dermatology 134 (6), 1768, 2014 | 30 | 2014 |
| Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas? L Emdad, ZA Qadeer, LB Bederson, HP Kothari, M Uzzaman, IM Germano Neuro-oncology 13 (7), 725-735, 2011 | 24 | 2011 |
| Prevalence of the Operon Encoding Subtilase Cytotoxin in Non-O157 Shiga Toxin-Producing Escherichia coli Isolated from Humans in the United States JJ Wolfson, DM Jandhyala, LA Gorczyca, Z Qadeer, SD Manning, ... Journal of clinical microbiology 47 (9), 3058-3059, 2009 | 17 | 2009 |
| ATRX and DAXX: mechanisms and mutations. Cold Spring Harb. Perspect. Med. 7, a026567 MA Dyer, ZA Qadeer, D Valle-Garcia, E Bernstein | 11 | 2017 |
| DDDR-32. A NEW IMMUNOMODULATORY FUNCTION OF PYRIDO-PYRIMIDINE DERIVATIVES TO IMPAIR METASTATIC GROUP 3 MEDULLOBLASTOMA IN VIVO M Zollo, F Asadzadeh, V Ferrucci, P De Antonellis, F Bibbò, R Siciliano, ... Neuro-Oncology 24 (Supplement_7), vii106-vii106, 2022 | 1 | 2022 |
| A SHHecret target of relapsed medulloblastoma: Astrocytes ZA Qadeer, WA Weiss The Journal of Experimental Medicine 218 (9), e20211141, 2021 | 1 | 2021 |
| Correction: Corrigendum: Current drive at plasma densities required for thermonuclear reactors R Cesario, L Amicucci, A Cardinali, C Castaldo, M Marinucci, ... Nature Communications 4 (1), 2282, 2013 | 1 | 2013 |
| MDB-08. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF POLYCOMB TARGETS ZA Qadeer, S Westelman, MO Johnson, E Hou, S Grele, K Smith, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| MYC and TGFβ promote group 3 medulloblastoma tumor resistance through deregulation of Polycomb targets ZA Qadeer, S Westelman, MO Johnson, E Hou, S Grele, K Smith, ... Cancer Research 84 (6_Supplement), 2848-2848, 2024 | | 2024 |
| Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma V Daggubati, A Vykunta, A Choudhury, Z Qadeer, K Mirchia, O Saulnier, ... Research Square, rs. 3. rs-3058335, 2023 | | 2023 |
| MDB-07. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF KDM2B TARGETS Z Qadeer, S Westelman, M Johnson, S Grele, E Hou, L Hendrikse, ... Neuro-Oncology 25 (Suppl 1), i62, 2023 | | 2023 |
| TARGETING TGF. PATHWAY DEPENDENCIES IN GROUP 3 MEDULLOBLASTOMA Z Qadeer, S Westelman, M Johnson, S Grele, L Hendrikse, M Taylor, ... NEURO-ONCOLOGY 24, 106-106, 2022 | | 2022 |
